Paid Clinical Trials in Milford, MA
As of August 2026, 24 paid clinical trials are recruiting in Milford, Massachusetts. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Milford offers studies at sites including Dana-Farber/Brigham and Women's Cancer Center at Milford Regional for conditions such as Breast Cancer, Plaque Psoriasis, Triple Negative Breast Cancer, Advanced Esophageal Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Milford
Trials by drug in Milford
Filter results
24 clinical trials
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
Androgen-responsive POSLUMA-guided Intra-prostatic Boost
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Enhanced Local Intensified Radiation Therapy in Elderly Glioblastoma: A Phase 2 Hybrid Randomized Trial
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
Top Research Study Locations in Milford
Researchers run research studies in Milford, MA at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dana-Farber/Brigham and Women's Cancer Center at Milford Regional | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 7 |
| Dana-Farber Brigham Cancer Center at Milford Regional Medical Center | Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases | 2 |
| Kuchnir Dermatology & Dermatologic Surgery | Plaque Psoriasis | 2 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| DFCI @ Milford Regional Hospital | Breast Cancer, PD-L1 Negative, Triple Negative Breast Cancer | 1 |
| Dana Farber Brigham Women Cancer | Early Breast Cancer | 1 |
| Dana Farber Cancer Institute @ Milford Regional Hospital | Triple Negative Breast Cancer | 1 |
| Dana Farber Cancer Institute at Milford Regional Medical Center | B-cell Malignancy, Low-grade, Hematological Malignancies, IgG Monoclonal Gammopathy of Uncertain Significance | 1 |
| Dana-Farber Brigham Cancer Center, Milford Hospital | Glioblastoma (GBM) | 1 |
| Dana-Farber Brigham and Womens Cancer Center at Milford Regional | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Dana-Farber Cancer Institute at Milford Regional | Breast Cancer | 1 |
| Dana-Farber at Milford | Breast Cancer, HER2-positive Breast Cancer | 1 |
| Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center | High Risk Prostate Cancer, Intermediate Risk Prostate Cancer, Prostate Cancer | 1 |
| Galderma Investigationa | Atopic Dermatitis | 1 |
| Kuchnir Dermatology and Dermatological Surgery | Tinea Pedis | 1 |
| Oruka Therapeutics Investigative Site | Plaque Psoriasis | 1 |
Active & Upcoming Studies in Milford (2026)
Recruiting trials in Milford grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (17 active studies)
- Androgen-responsive POSLUMA-guided Intra-prostatic Boost · Phase 2 · Martin T. King, MD, PhD
- Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · Phase 3 · Alliance for Clinical Trials in Oncology
Common conditions studied in Milford
- Breast Cancer (3 active studies)
- Plaque Psoriasis (3 active studies)
- Triple Negative Breast Cancer (2 active studies)
- Advanced Esophageal Adenocarcinoma (1 active study)
- Advanced Gastric Adenocarcinoma (1 active study)
- Advanced Gastroesophageal Junction Adenocarcinoma (1 active study)
Leading research sponsors in Milford
- Alliance for Clinical Trials in Oncology
- Dana-Farber Cancer Institute
- Bristol-Myers Squibb
- NRG Oncology
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Milford?
There are approximately 24 recruiting clinical trials in Milford, Massachusetts listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Milford pay participants?
Most recruiting trials in Milford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Milford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Milford?
The most common conditions under active study in Milford include Breast Cancer (3), Plaque Psoriasis (3), Triple Negative Breast Cancer (2), Advanced Esophageal Adenocarcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Milford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Milford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Milford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Milford?
Recruiting research sites in Milford include Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Dana-Farber Brigham Cancer Center at Milford Regional Medical Center, Kuchnir Dermatology & Dermatologic Surgery, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Milford right now?
The largest active categories in Milford are Cancer & tumors (17). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.